Apoptotic mechanisms in mutant LRRK2-mediated cell death

被引:157
作者
Iaccarino, Ciro
Crosio, Claudia
Vitale, Carmine
Sanna, Giovanna
Carrri, Maria Teresa
Barone, Paolo
机构
[1] Univ Naples Federico II, Dept Neurol Sci, I-80131 Naples, Italy
[2] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy
[3] CERC, Fdn Santa Lucia IRCCS, I-00143 Rome, Italy
[4] Ist Diagnost & Cura Hermitage Capodimonte, I-80143 Naples, Italy
[5] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
关键词
D O I
10.1093/hmg/ddm080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the gene coding for leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant Parkinson's disease. The pathological mutations have been associated with an increase of LRRK2 kinase activity, although its physiological substrates have not been identified yet. The data we report here demonstrate that disease-associated mutant LRRK2 cell toxicity is due to mitochondria-dependent apoptosis. Transient transfeclion of mutant LRRK2 leads to neuronal death with clear apoptotic signs. Soluble caspase inhibitors or the genetic ablation of Apaf1 protects cells from apoptotic death. Moreover, we explored the function of two protein domains in LRRK2 (LRR and WD40) and demonstrate that the lack of these protein domains has a protective effect on mitochondria dysfunctions induced by mutant LRRK2.
引用
收藏
页码:1319 / 1326
页数:8
相关论文
共 39 条
  • [1] Expanding insights of mitochondrial dysfunction in Parkinson's disease
    Abou-Sleiman, PM
    Muqit, MMK
    Wood, NW
    [J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) : 207 - 219
  • [2] PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
    Adams, JR
    van Netten, H
    Schulzer, M
    Mak, E
    Mckenzie, J
    Strongosky, A
    Sossi, V
    Ruth, TJ
    Lee, CS
    Farrer, M
    Gasser, T
    Uitti, RJ
    Calne, DB
    Wszolek, ZK
    Stoessl, AJ
    [J]. BRAIN, 2005, 128 : 2777 - 2785
  • [3] Localization of LRRK2 to membranous and vesicular structures in mammalian brain
    Biskup, Saskia
    Moore, Darren J.
    Celsi, Fulvio
    Higashi, Shinji
    West, Andrew B.
    Andrabi, Shaida A.
    Kurkinen, Kaisa
    Yu, Seong-Woon
    Savitt, Joseph M.
    Waldvogel, Henry J.
    Faull, Richard L. M.
    Emson, Piers C.
    Torp, Reldun
    Ottersen, Ole P.
    Dawson, Ted M.
    Dawson, Valina L.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 (05) : 557 - 569
  • [4] The LRRK2-G2019S mutation:: opening a novel era in Parkinson's disease genetics
    Bonifati, Vincenzo
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2006, 14 (10) : 1061 - 1062
  • [5] Apaf1 mediates apoptosis and mitochondrial damage induced by mutant human SOD1s typical of familial amyotrophic lateral sclerosis
    Cozzolino, M
    Ferri, A
    Ferraro, E
    Rotilio, G
    Cecconi, F
    Carrì, MT
    [J]. NEUROBIOLOGY OF DISEASE, 2006, 21 (01) : 69 - 79
  • [6] Apoptosome inactivation rescues proneural and neural cells from neurodegeneration
    Cozzolino, M
    Ferraro, E
    Ferri, A
    Rigamonti, D
    Quondamatteo, F
    Ding, H
    Xu, ZS
    Ferrari, F
    Angelini, DF
    Rotilio, G
    Cattaneo, E
    Carri, MT
    Cecconi, F
    [J]. CELL DEATH AND DIFFERENTIATION, 2004, 11 (11) : 1179 - 1191
  • [7] Mitotic phosphorylation of histone H3: Spatio-temporal regulation by mammalian aurora kinases
    Crosio, C
    Fimia, GM
    Loury, R
    Kimura, M
    Okano, Y
    Zhou, HY
    Sen, S
    Allis, CD
    Sassone-Corsi, P
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (03) : 874 - 885
  • [8] Parkinson's disease: Mechanisms and models
    Dauer, W
    Przedborski, S
    [J]. NEURON, 2003, 39 (06) : 889 - 909
  • [9] Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease
    Eberhardt, O
    Schulz, JB
    [J]. TOXICOLOGY LETTERS, 2003, 139 (2-3) : 135 - 151
  • [10] Genetics of Parkinson disease: paradigm shifts and future prospects
    Farrer, MJ
    [J]. NATURE REVIEWS GENETICS, 2006, 7 (04) : 306 - 318